about
Is the central nervous system a reservoir of HIV-1?Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4(+) T-cell subsets, including stem cell memory T-cellsEarly IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users.Longitudinal Analysis of CCR5 and CXCR4 Usage in a Cohort of Antiretroviral Therapy-Naïve Subjects with Progressive HIV-1 Subtype C Infection.Impaired hepatitis C virus (HCV)-specific interferon-γ responses in individuals with HIV who acquire HCV infection: correlation with CD4(+) T-cell counts.A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutationsMaintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment.Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc.Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users.Quantifying susceptibility of CD4+ stem memory T-cells to infection by laboratory adapted and clinical HIV-1 strains.Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapyAnalysis of clinical HIV-1 strains with resistance to maraviroc reveals strain-specific resistance mutations, variable degrees of resistance, and minimal cross-resistance to other CCR5 antagonists.The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets.Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancer.T cell therapies-are T memory stem cells the answer?
P50
Q34434339-CE6EE77E-DF22-404F-874D-E67AC942F6DAQ34537513-A97FDFF5-A708-461C-95D0-013034580ED9Q34777709-AD347479-DE7A-4505-BFCE-1CDF3BF9A929Q34792976-08D0DF61-A23C-4BA0-9DA2-4A2F3D568B9BQ36330949-AD5CE31F-C1F5-497C-9D01-41D28BCADD00Q36827946-E944D90C-B65B-44CB-9615-18AADE4C2CAEQ37255644-91389B19-40C9-413F-9319-88BEBFAD7406Q37362368-D584CB65-437A-45AE-AB3D-DB7D15023400Q37390786-4942684B-FEA8-4129-9463-D0689E34CE6CQ37540482-409FFCC0-8082-428F-A929-6DC470757CBBQ37611831-9E034484-4364-4D03-9C74-C6C947D42B96Q37690485-57E5C7B3-D000-40F9-8BA0-7BDA45100C46Q39006922-1AABA05F-93FE-4671-BABA-0026292E390AQ39163578-0A8FCF00-BFCF-4E6B-9BDB-2DAE90EF42A9Q39399821-2BAE0239-6B06-474E-8CBB-21F208CCCA07Q40895848-A1104C7A-9CDE-418B-B0F1-CEFD8B056904
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jacqueline K Flynn
@ast
Jacqueline K Flynn
@en
Jacqueline K Flynn
@es
Jacqueline K Flynn
@nl
type
label
Jacqueline K Flynn
@ast
Jacqueline K Flynn
@en
Jacqueline K Flynn
@es
Jacqueline K Flynn
@nl
prefLabel
Jacqueline K Flynn
@ast
Jacqueline K Flynn
@en
Jacqueline K Flynn
@es
Jacqueline K Flynn
@nl
P106
P1153
55650552400
P31
P496
0000-0002-3822-294X